Rhinitis medicamentosa

Rhinitis medicamentosa
Other namesRebound congestion
SpecialtyOtorhinolaryngology
SymptomsNasal congestion
Usual onsetAfter 5–7 days of use of topical decongestant nasal sprays
CausesOveruse of decongestant nasal sprays and certain oral medications
PreventionLimiting use of decongestant nasal sprays and other potentially problematic medications
TreatmentCeasing use of offending medications

Rhinitis medicamentosa (or RM, also known as rebound congestion) is a condition of rebound nasal congestion suspected to be brought on by extended use of topical decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline, and naphazoline nasal sprays) and certain oral medications (e.g., sympathomimetic amines and various 2-imidazolines) that constrict blood vessels in the lining of the nose, although evidence has been contradictory.[1]

  1. ^ Mortuaire, G.; de Gabory, L.; François, M.; Massé, G.; Bloch, F.; Brion, N.; Jankowski, R.; Serrano, E. (June 2013). "Rebound congestion and rhinitis medicamentosa: Nasal decongestants in clinical practice. Critical review of the literature by a medical panel". European Annals of Otorhinolaryngology, Head and Neck Diseases. 130 (3): 137–144. doi:10.1016/j.anorl.2012.09.005. PMID 23375990.